Oncological pediatric early warning score: a dedicated tool to predict patient's clinical deterioration and need for pediatric intensive care treatment.

Oncology PICU outcome pediatric warning score

Journal

Pediatric hematology and oncology
ISSN: 1521-0669
Titre abrégé: Pediatr Hematol Oncol
Pays: England
ID NLM: 8700164

Informations de publication

Date de publication:
08 Jul 2024
Historique:
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: aheadofprint

Résumé

Pediatric oncohematological patients frequently require PICU admission during their clinical history. The O-PEWS is a specific score developed to predict the need for PICU admission of oncohematological children. This study aimed at i) describing the trend of the O-PEWS in a cohort of patients hospitalized in the Pediatric Oncohematology ward and transferred to the PICU of Padua University Hospital, measured at different time-points in the 24 hours before PICU admission and to evaluate its association with mortality and presence of organ failure; ii) investigating the association between the recorded O-PEWS, and PIM3, number of organ failure and the need for ventilation, dialysis and inotropes. This retrospective single-center study enrolled oncohematological children admitted to the PICU between 2017 and 2021. The O-PEWS, ranging between 0 and 15, was calculated on the available medical records and the TIPNet-Network database at 24 (T-24), 12 (T-12), 6 (T-6) and 0 (T0) hours before PICU admission. RESULTS: 101 PICU admissions, related to 80 children, were registered. During the 24 hours prior to PICU admission, the O-PEWS progressively increased in all the patients. At T-24 the median O-PEWS was 3 (IQR 1-5), increasing to a median value of 6 (IQR 4-8) at T0. The O-PEWS was positively associated with mortality, organ failure and the need for ventilation at all the analyzed time-points and with the need for dialysis at T-6. The O-PEWS appears as a useful tool for predicting early clinical deterioration in oncohematological patients and for anticipating the initiation of life-support treatments.

Identifiants

pubmed: 38973711
doi: 10.1080/08880018.2024.2355543
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Auteurs

Teresa Maccarana (T)

University of Padova, Padova, Italy.

Marta Pillon (M)

Pediatric Hematology, Oncology and Stem Cell Transplant Division, Department of Woman's and Child's Health, University-Hospital of Padova, Padova, Italy.

Veronica Bertozzi (V)

University of Padova, Padova, Italy.

Elisa Carraro (E)

Pediatric Hematology, Oncology and Stem Cell Transplant Division, Department of Woman's and Child's Health, University-Hospital of Padova, Padova, Italy.

Elena Cavallaro (E)

Pediatric Hematology, Oncology and Stem Cell Transplant Division, Department of Woman's and Child's Health, University-Hospital of Padova, Padova, Italy.

Claudia Maria Bonardi (CM)

Pediatric Intensive Care Unit, Department of Woman's and Child's Health, University-Hospital of Padova, Padova, Italy.

Luca Marchetto (L)

Pediatric Intensive Care Unit, Department of Woman's and Child's Health, University-Hospital of Padova, Padova, Italy.

Giulia Reggiani (G)

Pediatric Hematology, Oncology and Stem Cell Transplant Division, Department of Woman's and Child's Health, University-Hospital of Padova, Padova, Italy.

Annalisa Tondo (A)

Meyer Children's Hospital IRCCS', Firenze, Italy.

Camilla Rosa (C)

Meyer Children's Hospital IRCCS', Firenze, Italy.

Rosanna Irene Comoretto (RI)

Department of Public Health and Pediatrics, University of Torino, Torino, Italy.

Angela Amigoni (A)

Pediatric Intensive Care Unit, Department of Woman's and Child's Health, University-Hospital of Padova, Padova, Italy.

Alessandra Biffi (A)

Pediatric Hematology, Oncology and Stem Cell Transplant Division, Department of Woman's and Child's Health, University-Hospital of Padova, Padova, Italy.

Classifications MeSH